Stock Research: Chong Kun Dang

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Chong Kun Dang

KOSE:A185750 KR7185750007
31
  • Value
    50
  • Growth
    4
  • Safety
    Safety
    53
  • Combined
    14
  • Sentiment
    76
  • 360° View
    360° View
    31
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Chong Kun Dang Pharmaceutical Corp manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs, quasi-drugs, and health functional foods. The company operates in the pharmaceutical and healthcare industries, with products including antidiabetic treatments, cerebrovascular disease treatments, and OTC drugs like penzal. It sells products domestically and internationally. In the last fiscal year, the company had a market cap of $821 million, profits of $361 million, and revenue of $1074 million. The number of employees is not available.

more
Index
KOSPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
50 46 34 51
Growth
4 6 93 15
Safety
Safety
53 65 34 55
Sentiment
76 76 98 73
360° View
360° View
31 46 85 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
73 88 69 82
Opinions Change
50 26 64 50
Pro Holdings
n/a 64 80 10
Market Pulse
93 76 89 93
Sentiment
76 76 98 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
50 46 34 51
Growth
4 6 93 15
Safety Safety
53 65 34 55
Combined
14 49 50 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
43 51 40 51
Price vs. Earnings (P/E)
86 84 70 87
Price vs. Book (P/B)
45 43 29 39
Dividend Yield
38 34 31 32
Value
50 46 34 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
34 27 21 40
Profit Growth
9 11 89 16
Capital Growth
9 31 84 85
Stock Returns
38 26 93 5
Growth
4 6 93 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
45 43 31 40
Refinancing
66 80 53 71
Liquidity
41 57 45 47
Safety Safety
53 65 34 55

Similar Stocks

Discover high‑ranked alternatives to Chong Kun Dang and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

KT

KOSE:A030200
Country: South Korea
Industry: Integrated Telecommunication
Size: Large
Full Stock Analysis

NH Investment & Securities

KOSE:A005940
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Medium
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: